2-(2-Cyclopropoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98.0%, 100mg

5,6-Methyl-1,3-dihydro-2H-benzimidazol-2-one, 95.0%, 100g

Benzyl (4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)carbamate, 95.0%, 100g

2,6-Dichloropyridine-N-oxide, 98.0%, 1g

13-Oxa-6,7-dithia-2,11-diazapentadecanoic acid, 3,10-dicarboxy-14,14-dimethyl-12-oxo-, 1-(1,1-dimethylethyl) ester, [R-(R*,R*)]- 9CI, ?97.0%, 1g

Boc-dl-2-Aminotetralin-2-carboxylic acid, 95.0%, 5g

4-Propoxybenzoic acid, 98.0%, 1g

Copper(II) Phthalocyanine (beta-form)>93.0%(T)500g

1-hydroxyl-1H-pyridine-2-thione, 5g

4,4'-Sulfonyldibenzoic acid, 98.0%, 25g

7-Methoxy-4-(trifluoromethyl)-2H-chromen-2-one, 97%, 250mg

Hexan (Isomeren), min. 95 % (isomere), zur Synthese, 10 l, Weißbl.

4-(1,2,4-Oxadiazol-3-yl)benzoic acid, 95%, 100mg